BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2857891)

  • 1. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 2. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.
    Kitchen LW; Barin F; Sullivan JL; McLane MF; Brettler DB; Levine PH; Essex M
    Nature; 1984 Nov 22-28; 312(5992):367-9. PubMed ID: 6095094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
    Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in prevalence of anti-HTLV-III in haemophiliacs.
    Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
    Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
    [No Abstract]   [Full Text] [Related]  

  • 5. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
    Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
    Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
    McFadden T; Jason JM; Feorino P
    JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Felding P; Nilsson IM; Hansson BG; Biberfeld G
    Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state].
    Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F
    Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
    van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
    [No Abstract]   [Full Text] [Related]  

  • 13. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
    Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
    Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes.
    Giudizi MG; Biagiotti R; Almerigogna F; Mazzetti M; Alessi A; Massai G; Longo G; Scano G; Morfini M; Romagnani S
    Scand J Haematol; 1986 Feb; 36(2):198-202. PubMed ID: 2422735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
    Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.